EGFR and colorectal cancer: EGFR is highly expressed in many cancers and amplified in 8.5% of solid tumors, including colorectal cancer (16.3%), non-small cell lung cancer (9%), genitourinary cancers (8.1%), and breast cancer (7.3%) (13).